{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:36Z","timestamp":1786119336754,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:p>Little is known about the fetal\u2013neonatal pharmacokinetics of maternally administered, weight-based vancomycin dosing for group B streptococcus (GBS) intrapartum antibiotic prophylaxis. Our objective was to quantify vancomycin concentrations in umbilical cord blood at birth after weight-based maternal intrapartum vancomycin administration and to assess cord blood vancomycin levels relative to the established GBS clinical minimum inhibitory concentration (MIC) breakpoint. Using a convenience sample of stored sera from our biorepository, we measured vancomycin levels in umbilical cord blood from 26 neonates after maternal intrapartum vancomycin exposure. Most neonates (24\/26, 92.3%; 95% CI, 74.9\u201399.1%) had vancomycin cord blood levels above the MIC breakpoint (1 microgram\/mL or higher) for GBS.<\/jats:p>","DOI":"10.1097\/aog.0000000000005843","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T17:00:26Z","timestamp":1738861226000},"page":"435-438","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Vancomycin Concentrations in Umbilical Cord Blood After Intrapartum Exposure"],"prefix":"10.1097","volume":"145","author":[{"given":"Sarah A.","family":"Coggins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly C.","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Downes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M.","family":"Puopolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"R1-20250320","doi-asserted-by":"crossref","first-page":"e20191881","DOI":"10.1542\/peds.2019-1881","article-title":"Management of infants at risk for group B streptococcal disease","volume":"144","author":"Puopolo","year":"2019","journal-title":"Pediatrics"},{"key":"R2-20250320","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1097\/AOG.0000000000003668","article-title":"Prevention of group B streptococcal early-onset disease in newborns. ACOG Committee Opinion Number 797. American College of Obstetricians and Gynecologists","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R3-20250320","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/01.AOG.0000260388.78339.b6","article-title":"Transplacental passage of vancomycin in noninfected term pregnant women","volume":"109","author":"Laiprasert","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R4-20250320","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/14767058.2017.1306049","article-title":"Transplacental passage of vancomycin","volume":"31","author":"Towers","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R5-20250320","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","article-title":"Pharmacokinetics of drugs in pregnancy","volume":"39","author":"Feghali","year":"2015","journal-title":"Semin Perinatol"},{"key":"R6-20250320","doi-asserted-by":"crossref","first-page":"20182894","DOI":"10.1542\/peds.2018-2894","article-title":"Management of neonates born at \u226535 0\/7 weeks' gestation with suspected or proven early-onset bacterial sepsis","volume":"142","author":"Puopolo","year":"2018","journal-title":"Pediatrics"},{"key":"R8-20250320","doi-asserted-by":"crossref","first-page":"352.e1","DOI":"10.1016\/j.ajog.2014.01.019","article-title":"Transplacental passage of vancomycin from mother to neonate","volume":"210","author":"Onwuchuruba","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20250320","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s10096-018-3277-8","article-title":"Factors impacting unbound vancomycin concentrations in neonates and young infants","volume":"37","author":"Smits","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:18:18Z","timestamp":1786040298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005843","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"assertion":[{"value":"2024-10-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}